A promising breakthrough suggests that HIV might soon become a thing of the past, with scientists uncovering a potential cure that eradicates the virus from infected cells.

Currently, HIV can be managed, but not cured. However, a recent study introduced a potential HIV cure that employs molecular scissors to remove HIV DNA from infected cells. This groundbreaking approach utilizes CRISPR-Cas gene editing technology, enabling precise modifications to living organisms' genomes.

The groundbreaking CRISPR-Cas genome editing tool, celebrated with the 2020 Nobel Prize in Chemistry for its inventors Jennifer Doudna and Emmanuelle Charpentier, offers a precise method to target and modify specific DNA segments.

This technique addresses a major hurdle in HIV treatment, as the virus integrates its genome into the host's DNA, making elimination challenging. The authors highlight CRISPR-Cas as a promising avenue for targeting HIV DNA, potentially surpassing the efficacy of current antiviral medications.

Ahead of this year's European Congress of Clinical Microbiology and Infectious Diseases, researchers utilized CRISPR-Cas and two guide RNAs to target "conserved" HIV sequences. These regions represent parts of the virus genome that remain consistent across all known HIV strains.

By concentrating on these conserved sections, the study aimed to develop a treatment capable of addressing various HIV variants efficiently, resulting in a cure for HIV-infected T-cells.

These regions represent parts of the virus genome that remain consistent across all known HIV strains. By concentrating on these conserved sections, the study aimed to develop a treatment capable of addressing various HIV variants efficiently, resulting in a cure for HIV-infected T cells.

Tags
Hiv